XNYS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Peter J. Bulgarelli, Executive Vice President of Outpatient Medical & Research at Ventas, officially separated from the company following his retirement on May 1, 2026. The departure was pre-announced, and a separ…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/14/2026 | RAKOWICH WALTER C | — | SELL | -1,152 | $90 | $103,915 |
| 5/13/2026 | BIGMAN THEODORE | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | EMBLER MICHAEL J | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | LUSTIG MATTHEW J | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | Martino Roxanne M | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | NADER MARGUERITE M | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | Nolan Sean P. | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | RAKOWICH WALTER C | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | Rodriguez Joe Vasquez Jr. | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | Roy Sumit | — | GRANT | 2,047 | $90 | $184,946 |
| 5/13/2026 | Smith Maurice S | — | GRANT | 2,047 | $90 | $184,946 |
| 5/1/2026 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | TAX_WITHHOLD | -1,496 | $88 | $131,678 |
| 5/1/2026 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | TAX_WITHHOLD | -2,372 | $88 | $208,783 |
| 5/1/2026 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | TAX_WITHHOLD | -2,346 | $88 | $206,495 |
| 4/16/2026 | Smith Maurice S | — | GRANT | 59.32 | $86 | $5,072 |
| 4/16/2026 | Smith Maurice S | — | GRANT | 66.74 | $86 | $5,707 |
| 4/16/2026 | Roy Sumit | — | GRANT | 49.72 | $86 | $4,251 |
| 4/16/2026 | Roy Sumit | — | GRANT | 66.74 | $86 | $5,707 |
| 4/16/2026 | Rodriguez Joe Vasquez Jr. | — | GRANT | 41.22 | $86 | $3,525 |
| 4/16/2026 | NADER MARGUERITE M | — | GRANT | 66.74 | $86 | $5,707 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 5/14/2026 | J.P. Morgan Securities LLC as agent and attorney-in-fact for Walter C. Rakowich | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 75,948,003 | $5,876,856,472 | — | 1/29/2026 |
| State Street | 29,662,635 | $2,309,234,430 | — | 2/13/2026 |
| Fidelity (FMR) | 29,281,079 | $2,265,769,881 | — | 2/17/2026 |
| BlackRock | 43,295,150 | $2,219,309,384 | — | 8/13/2024 |
| JP Morgan Chase | 28,376,464 | $2,195,770,881 | — | 2/11/2026 |
| AQR Capital | 2,982,633 | $230,796,131 | — | 2/17/2026 |
| Two Sigma | 1,624,797 | $125,726,792 | — | 2/17/2026 |
| Citadel Advisors | 1,363,504 | $105,507,939 | — | 2/17/2026 |
| DE Shaw | 380,173 | $29,417,787 | — | 2/17/2026 |
| Millennium Management | 337,346 | $26,103,833 | — | 2/17/2026 |
| Point72 | 176,334 | $13,644,725 | — | 2/17/2026 |
| Bridgewater Associates | 2,842 | $219,914 | — | 2/13/2026 |